Polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Group 1 : 5 mg of bromocriptine daily is administered . In the first week 1.25 mg and after that 1.25 mg weekly is added until 5 mg per day. Intervention 2: Group 2 : a daily dose of 1
Treatment - Drugs
Group 1 : 5 mg of bromocriptine daily is administered . In the first week 1.25 mg and after that 1.25 mg weekly is added until 5 mg per day.
Group 2 : a daily dose of 1000 mg of metformin is administered. In the first week 250 mg and after that 250 mg weekly is added until to 2 pills a day.
Sponsors
?Vice chancellor for research, Kermanshah University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 35 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria : menstrual cycles greater than 40 days; acnea; hirsutism; pco on sonography; LH/FSH ratio greater than 2; normal prolactin; normal TSH; excess androstenedione; normal blood sugar. Exclusion criteria: marriage; psychiatric drug users; professional athletes; primary amenorrhea; history of chronic illnesses; body mass index greater than 30 kg/m2.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Menstrual pattern. Timepoint: Before , 3 and 6 months after intervention. Method of measurement: Questionnaire, menstrual cycle days measurement. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFiroozeh Veisi
Vice chancellor for research, Kermanshah University of Medical Sciences, Kermanshah, Iran
Outcome results
None listed